Stavros Petrou

31.4k total citations · 11 hit papers
367 papers, 18.5k citations indexed

About

Stavros Petrou is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, Stavros Petrou has authored 367 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Economics and Econometrics, 103 papers in Pediatrics, Perinatology and Child Health and 102 papers in General Health Professions. Recurrent topics in Stavros Petrou's work include Health Systems, Economic Evaluations, Quality of Life (106 papers), Healthcare Policy and Management (65 papers) and Infant Development and Preterm Care (46 papers). Stavros Petrou is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (106 papers), Healthcare Policy and Management (65 papers) and Infant Development and Preterm Care (46 papers). Stavros Petrou collaborates with scholars based in United Kingdom, United States and Netherlands. Stavros Petrou's co-authors include Josephine Mauskopf, Don Husereau, Dan Greenberg, Elizabeth Loder, Andrew Briggs, Chris Carswell, Federico Augustovski, Michael Drummond, David Moher and Esther W. de Bekker‐Grob and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Stavros Petrou

349 papers receiving 18.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

2013 1.5k citations Stavros Petrou et al. profile →
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

2013 1.4k citations Stavros Petrou et al. BMJ profile →
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

2018 855 citations Annie Young, Andrea Marshall et al. Journal of Clinical Oncology profile →
Discrete Choice Experiments in Health Economics: A Review of the Literature

2014 607 citations Stavros Petrou et al. PharmacoEconomics profile →
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

2022 485 citations Stavros Petrou et al. profile →
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

2013 481 citations Stavros Petrou et al. profile →
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

2022 422 citations Stavros Petrou et al. profile →
CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

2013 411 citations Stavros Petrou et al. profile →
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

2022 218 citations Stavros Petrou et al. BMJ profile →
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

2022 181 citations Stavros Petrou et al. profile →
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

2022 148 citations Stavros Petrou et al. profile →

Peers

Countries citing papers authored by Stavros Petrou

Since Specialization

Citations

This map shows the geographic impact of Stavros Petrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stavros Petrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stavros Petrou more than expected).

Fields of papers citing papers by Stavros Petrou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stavros Petrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stavros Petrou. The network helps show where Stavros Petrou may publish in the future.

Co-authorship network of co-authors of Stavros Petrou

This figure shows the co-authorship network connecting the top 25 collaborators of Stavros Petrou. A scholar is included among the top collaborators of Stavros Petrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stavros Petrou. Stavros Petrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Socioeconomic inequality and access to emergency care: understanding the pathways to the emergency department in the UK 2025 ·BMJ Open ·Joan E. Madia, Adrian Boyle, James Ray, Alex Novak, Catherine Pope, (unknown), Stavros Petrou, Raphael Wittenberg, Catia Nicodemo	0
2	Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation 2024 ·Health Technology Assessment ·Oliver Rivero‐Arias, May Ee Png, (unknown), (unknown), (unknown), Lisa Hinton, Felicity Boardman, (unknown), Jane Fisher, B. Thilaganathan, Sam Oddie, Anne‐Marie Slowther, (unknown), Nia Roberts, (unknown), Stavros Petrou	2
3	Family Group Conference Provision in UK Local Authorities and Associations with Children Looked after Rates 2024 ·The British Journal of Social Work ·Sophie Wood, Jonathan Scourfield, (unknown), (unknown), Rhiannon Evans, (unknown), Fiona Lugg‐Widger, Philip Pallmann, Michael Robling, Liz Schroeder, Stavros Petrou, David Wilkins	2
4	Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT 2024 ·Health Technology Assessment ·Simon D. Kyle, Peter Bower, Ly‐Mee Yu, A Niroshan Siriwardena, Yaling Yang, Stavros Petrou, Emma Ogburn, (unknown), Leonie Maurer, Barbara Robinson, Caroline Gardner, (unknown), (unknown), Colin A. Espie, Paul Aveyard	2
5	Epidemiology of revision hip replacement surgery in the UK over the past 15 years—an analysis from the National Joint Registry 2023 ·BMJ Open ·Shiraz A. Sabah, Ruth Knight, Philippa Nicolson, Adrian Taylor, Benjamin Kendrick, Abtin Alvand, Stavros Petrou, David Beard, Andrew Price, Antony Palmer	5
6	Predicting 10-year breast cancer mortality risk in the general female population in England: a model development and validation study 2023 ·The Lancet Digital Health ·Ash Kieran Clift, Gary S. Collins, Simon Lord, Stavros Petrou, David Dodwell, Michael Brady, Julia Hippisley–Cox	11
7	Impact of Long COVID on productivity and informal caregiving 2023 ·The European Journal of Health Economics ·Joseph Kwon, Ruairidh Milne, (unknown), (unknown), (unknown), Ghazala Mir, Brendan Delaney, Manoj Sivan, Stavros Petrou	29
8	Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs) 2023 ·Social Science & Medicine ·(unknown), John Buckell, Stavros Petrou, Sarah Stewart‐Brown, Jason Madan	5
9	Systematic Review of the Relative Social Value of Child and Adult Health 2023 ·PharmacoEconomics ·Tessa Peasgood, Martin Howell, (unknown), (unknown), Marcus Sellars, Gang Chen, Joanna Coast, Jonathan C. Craig, Nancy Devlin, Kirsten Howard, Emily Lancsar, Stavros Petrou, Julie Ratcliffe, Rosalie Viney, Germaine Wong, Richard Norman, Cam Donaldson	6
10	Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study 2023 ·BMJ ·Ash Kieran Clift, David Dodwell, Simon Lord, Stavros Petrou, Michael Brady, Gary S. Collins, Julia Hippisley–Cox	46
11	Gestational age and hospital admission costs from birth to childhood: a population-based record linkage study in England 2023 ·Archives of Disease in Childhood Fetal & Neonatal ·Xinyang Hua, Stavros Petrou, Victoria Coathup, Claire Carson, Jennifer J. Kurinczuk, Maria Quigley, Elaine M. Boyle, Samantha Johnson, Alison Macfarlane, Oliver Rivero‐Arias	4
12	Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study 2022 ·BMJ Open ·Ashley Kieran Clift, Julia Hippisley–Cox, David Dodwell, Simon Lord, (unknown), Stavros Petrou, Gary S. Collins	8
13	No exponential rise in revision knee replacement surgery over the past 15 years: an analysis from the National Joint Registry 2022 ·Osteoarthritis and Cartilage ·Shiraz A. Sabah, Ruth Knight, Abtin Alvand, David W. Murray, Stavros Petrou, David Beard, Andrew Price	14
14	Cost of neonatal abstinence syndrome: an economic analysis of English national data held in the National Neonatal Research Database 2021 ·Archives of Disease in Childhood Fetal & Neonatal ·Philippa Rees, Ben Carter, Chris Gale, Stavros Petrou, Beverley Botting, Alastair Sutcliffe	3
15	Plaster cast versus functional bracing for Achilles tendon rupture: the UKSTAR RCT 2020 ·Health Technology Assessment ·Matthew L. Costa, Juul Achten, (unknown), Ioana R. Marian, Mandy Maredza, Michael Maia Schlüssel, (unknown), Nick Parsons, Susan Dutton, Rebecca Kearney, Sarah E Lamb, B. Ollivere, Stavros Petrou	12
16	Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) breakdown → 2018 ·Journal of Clinical Oncology ·Annie Young, Andrea Marshall, (unknown), Oliver Chapman, Anand Lokare, Catherine St. Hill, Danielle Hale, Janet Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay K. Kakkar, Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher Poole, Anthony Maraveyas, Mark N. Levine	855
17	Protocol of a randomised controlled trial of real-time continuous glucose monitoring in neonatal intensive care ‘REACT’ 2018 ·BMJ Open ·Kathryn Beardsall, Lynn Thomson, Catherine Guy, Mirjam M. van Weissenbruch, Isabel Iglesias‐Platas, Priya Muthukumar, (unknown), Simon Bond, Stavros Petrou, David B. Dunger	9
18	Gestational age and hospital utilization: three-years follow-up of an area-based birth cohort. 2017 ·PubMed ·Carlo Corchia, (unknown), Francesco Franco, Sara Farchi, Stavros Petrou, Domenico Di Lallo	5
19	Facet-joint injections for people with persistent non-specific low back pain (FIS): study protocol for a randomised controlled feasibility trial 2015 ·Trials ·Harbinder Sandhu, David R Ellard, Felix Achana, (unknown), (unknown), (unknown), Melinda Cairns, Frances Griffiths, Kirstie Haywood, Charles Hutchinson, Ranjit Lall, Stavros Petrou, Nigel Stallard, Colin Tysall, David A. Walsh, Martin Underwood	5
20	Community/palliative care 2001 ·Archives of Disease in Childhood ·Margaret Johnson, Unni Wariyar, Lesley Mutch, Frances Gardner, Ursula Bowler, P Yudkin, Christine Hockley, Stavros Petrou, Elisabeth Horak, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact